Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-04-18

FDA Approved: EYE ITCH RELIEF — Supplemental Application (Target Corporation)

View source ↗

Summary

FDA approves a supplemental application for Eye Itch Relief containing ketotifen fumarate, updating the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eye Itch Relief (Ketotifen fumarate)

Snippet

SUPPL AP for EYE ITCH RELIEF (KETOTIFEN FUMARATE)